ArticleCell death & disease2021

Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.

Alena Malyukova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.